DAXX safeguards heterochromatin formation in embryonic stem cells.
Chromocenters
DAXX
Embryonic stem cell
Heterochromatin
Histone variant H3.3
Nuclear periphery
PML
Pericentromere
SETDB1
Journal
Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457
Informations de publication
Date de publication:
01 Oct 2023
01 Oct 2023
Historique:
received:
24
02
2023
accepted:
25
08
2023
pubmed:
1
9
2023
medline:
1
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
Genomes comprise a large fraction of repetitive sequences folded into constitutive heterochromatin, which protect genome integrity and cell identity. De novo formation of heterochromatin during preimplantation development is an essential step for preserving the ground-state of pluripotency and the self-renewal capacity of embryonic stem cells (ESCs). However, the molecular mechanisms responsible for the remodeling of constitutive heterochromatin are largely unknown. Here, we identify that DAXX, an H3.3 chaperone essential for the maintenance of mouse ESCs in the ground state, accumulates in pericentromeric regions independently of DNA methylation. DAXX recruits PML and SETDB1 to promote the formation of heterochromatin, forming foci that are hallmarks of ground-state ESCs. In the absence of DAXX or PML, the three-dimensional (3D) architecture and physical properties of pericentric and peripheral heterochromatin are disrupted, resulting in de-repression of major satellite DNA, transposable elements and genes associated with the nuclear lamina. Using epigenome editing tools, we observe that H3.3, and specifically H3.3K9 modification, directly contribute to maintaining pericentromeric chromatin conformation. Altogether, our data reveal that DAXX is crucial for the maintenance and 3D organization of the heterochromatin compartment and protects ESC viability.
Identifiants
pubmed: 37655670
pii: 326618
doi: 10.1242/jcs.261092
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agence Nationale pour le Developpement de la Recherche Universitaire
ID : ANR-16-CE12-0003-01
Organisme : Ligue Contre le Cancer
ID : RS22/75-43
Organisme : Agence Nationale de la Recherche
ID : ANR-16-CE12-0003-01
Organisme : La Ligue Nationale Contre le Cancer
ID : RS22/75-43
Organisme : IDEX SLI
ID : DXCAIHUSLI-EF14
Informations de copyright
© 2023. Published by The Company of Biologists Ltd.
Déclaration de conflit d'intérêts
Competing interests The authors declare no competing or financial interests.